Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends | 15/09/2022 - 15/09/2022 | France, Sophia Antipolis Cedex | Website | Cardiology | European Society of Cardiology (ESC) | 0.0 European CME credits (ECMEC®) |
